Preventative measures recommended in the prevention of urinary tract infections include early removal of foreign bodies including stents and in-dwelling catheters as well as daily trimethoprim-sulfamethoxazole or nitrofurantoin [ 18] for those with allergies or G6PD deficiencies for at least 6 months after transplantation during the early transplant phase.
There are 3 phases of hematopoietic cell transplantation, ie, phase I (pre-engraftment), phase II (postengraftment, <100 days posttransplant), and phase III (late phase, >100 days posttransplant).
Graft failure and delayed haematopoietic and immune reconstitution are the main reasons for transplantation-related morbidity and mortality at early post-transplantation phases.
One steady-state concentration was collected for each patient in the early post-transplant phase, i.e. 2 to 7 weeks after transplantation.
Aversa, A. Terenzi, A. Tabilio, et al., Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse, J. Clin.
Invasive candidiasis generally occurred in the posthematopoietic cell transplantation engraftment phase II (day 61), earlier than the onset of other invasive fungal infections.
The collagen scaffolds were believed to support the survival of transplanted cells at the initial phase of transplantation in vivo.
This cytoprotective phenotype is maintained for at least 5 days after the hypoxic stimulus, thereby promoting cell survival during the critical acute phase after transplantation, during which 30 90% of transplanted cells succumb to environmental stresses within the host milieu.
Furthermore, the presence of depression and anxiety during the acute phase of transplantation predicts functional status, social function and generic quality of life after transplantation [ 3].
Further, we have applied a lung-protective ventilatory strategy in the donor animals and during the reperfusion phase of transplantation and measured gene expression of important cytokines, chemokines and markers of endothelial activation throughout the protocol.
